The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

James M. Swanson

Department of Pediatrics

University of California

Irvine

School of Medicine

USA

[email]@uci.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Pediatrics, University of California, Irvine, School of Medicine, USA. 1998 - 2009
  • Professor of Pediatrics, UCI Child Development Center, Centerpointe Plaza, 19722 MacArthur Blvd., (Email). 2005

References

  1. Developmental origins of health and disease: environmental exposures. Swanson, J.M., Entringer, S., Buss, C., Wadhwa, P.D. Semin. Reprod. Med. (2009) [Pubmed]
  2. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. Swanson, J., Arnold, L.E., Kraemer, H., Hechtman, L., Molina, B., Hinshaw, S., Vitiello, B., Jensen, P., Steinhoff, K., Lerner, M., Greenhill, L., Abikoff, H., Wells, K., Epstein, J., Elliott, G., Newcorn, J., Hoza, B., Wigal, T. J. Atten. Disord (2008) [Pubmed]
  3. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details. Swanson, J., Arnold, L.E., Kraemer, H., Hechtman, L., Molina, B., Hinshaw, S., Vitiello, B., Jensen, P., Steinhoff, K., Lerner, M., Greenhill, L., Abikoff, H., Wells, K., Epstein, J., Elliott, G., Newcorn, J., Hoza, B., Wigal, T. J. Atten. Disord (2008) [Pubmed]
  4. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. Swanson, J.M., Elliott, G.R., Greenhill, L.L., Wigal, T., Arnold, L.E., Vitiello, B., Hechtman, L., Epstein, J.N., Pelham, W.E., Abikoff, H.B., Newcorn, J.H., Molina, B.S., Hinshaw, S.P., Wells, K.C., Hoza, B., Jensen, P.S., Gibbons, R.D., Hur, K., Stehli, A., Davies, M., March, J.S., Conners, C.K., Caron, M., Volkow, N.D. J. Am. Acad. Child. Adolesc. Psychiatry (2007) [Pubmed]
  5. Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. Swanson, J.M., Hinshaw, S.P., Arnold, L.E., Gibbons, R.D., Marcus, S., Hur, K., Jensen, P.S., Vitiello, B., Abikoff, H.B., Greenhill, L.L., Hechtman, L., Pelham, W.E., Wells, K.C., Conners, C.K., March, J.S., Elliott, G.R., Epstein, J.N., Hoagwood, K., Hoza, B., Molina, B.S., Newcorn, J.H., Severe, J.B., Wigal, T. J. Am. Acad. Child. Adolesc. Psychiatry (2007) [Pubmed]
  6. Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). Swanson, J.M., Moyzis, R.K., McGough, J.J., McCracken, J.T., Riddle, M.A., Kollins, S.H., Greenhill, L.L., Abikoff, H.B., Wigal, T., Wigal, S.B., Posner, K., Skrobala, A.M., Davies, M., Ghuman, J.K., Cunningham, C., Vitiello, B., Stehli, A., Smalley, S.L., Grady, D. J. Child. Adolesc. Psychopharmacol (2007) [Pubmed]
  7. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Swanson, J.M., Kinsbourne, M., Nigg, J., Lanphear, B., Stefanatos, G.A., Volkow, N., Taylor, E., Casey, B.J., Castellanos, F.X., Wadhwa, P.D. Neuropsychol. Rev (2007) [Pubmed]
  8. Stimulant-related reductions of growth rates in the PATS. Swanson, J., Greenhill, L., Wigal, T., Kollins, S., Stehli, A., Davies, M., Chuang, S., Vitiello, B., Skrobala, A., Posner, K., Abikoff, H., Oatis, M., McCracken, J., McGough, J., Riddle, M., Ghuman, J., Cunningham, C., Wigal, S. J. Am. Acad. Child. Adolesc. Psychiatry (2006) [Pubmed]
  9. Using long-acting stimulants: does it change ADHD treatment outcome?. Swanson, J.M., Hechtman, L. Canadian. Child. Adolescent. Psychiatry. Review. =. La. Revue. Canadienne. Psychiatrie. L'enfant. Et. L'adolescent (2005) [Pubmed]
  10. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). Swanson, J.M., Wigal, S.B., Wigal, T., Sonuga-Barke, E., Greenhill, L.L., Biederman, J., Kollins, S., Nguyen, A.S., DeCory, H.H., Hirshe Dirksen, S.J., Hatch, S.J. Pediatrics (2004) [Pubmed]
  11. Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement. Swanson, J. CNS. Drugs (2003) [Pubmed]
  12. Serum and brain concentrations of methylphenidate: implications for use and abuse. Swanson, J.M., Volkow, N.D. Neurosci. Biobehav. Rev (2003) [Pubmed]
  13. Role of executive function in ADHD. Swanson, J.M. J. Clin. Psychiatry (2003) [Pubmed]
  14. Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD. Swanson, J.M., Volkow, N.D. Behav. Brain Res. (2002) [Pubmed]
  15. Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA. Swanson, J.M., Arnold, L.E., Vitiello, B., Abikoff, H.B., Wells, K.C., Pelham, W.E., March, J.S., Hinshaw, S.P., Hoza, B., Epstein, J.N., Elliott, G.R., Greenhill, L.L., Hechtman, L., Jensen, P.S., Kraemer, H.C., Kotkin, R., Molina, B., Newcorn, J.H., Owens, E.B., Severe, J., Hoagwood, K., Simpson, S., Wigal, T., Hanley, T. J. Abnorm. Child. Psychol (2002) [Pubmed]
  16. The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications. Swanson, J.M., Lerner, M., Wigal, T., Steinhoff, K., Greenhill, L., Posner, K., Freid, J., Wigal, S. J. Atten. Disord (2002) [Pubmed]
  17. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. Swanson, J.M., Kraemer, H.C., Hinshaw, S.P., Arnold, L.E., Conners, C.K., Abikoff, H.B., Clevenger, W., Davies, M., Elliott, G.R., Greenhill, L.L., Hechtman, L., Hoza, B., Jensen, P.S., March, J.S., Newcorn, J.H., Owens, E.B., Pelham, W.E., Schiller, E., Severe, J.B., Simpson, S., Vitiello, B., Wells, K., Wigal, T., Wu, M. J. Am. Acad. Child. Adolesc. Psychiatry (2001) [Pubmed]
  18. Dopamine genes and ADHD. Swanson, J.M., Flodman, P., Kennedy, J., Spence, M.A., Moyzis, R., Schuck, S., Murias, M., Moriarity, J., Barr, C., Smith, M., Posner, M. Neurosci. Biobehav. Rev (2000) [Pubmed]
  19. Analog classroom assessment of Adderall in children with ADHD. Swanson, J.M., Wigal, S., Greenhill, L.L., Browne, R., Waslik, B., Lerner, M., Williams, L., Flynn, D., Agler, D., Crowley, K., Fineberg, E., Baren, M., Cantwell, D.P. J. Am. Acad. Child. Adolesc. Psychiatry (1998) [Pubmed]
 
WikiGenes - Universities